Quality of Outcome Reporting for Older Subgroups in FDA Registration Gastroesophageal Cancer Trials (2010–2024): A Systematic Review
Simple Summary Older adults are commonly excluded from drug trials, causing physicians to make treatment decisions based on younger and fitter patients, which may lead to inadequate treatment of older patients. This study assesses publications from practice-changing drug trials in gastroesophageal adenocarcinoma from 2...